A growth-hormone-releasing peptide studied for reducing visceral (deep abdominal) fat.
Tesamorelin is a GHRH analog. A brand-name version is FDA-approved for reducing excess abdominal fat in a specific patient population. Compounded versions are prescribed off-label.
Possible side effects include injection-site reactions, joint pain, and changes in blood sugar. Your provider reviews your history and labs before prescribing.
Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Program disclaimers
Tell us about your goals and health history. About 2 minutes.
A licensed U.S. provider reviews your intake and any labs, then writes your plan if you're a fit.
Ships free in discreet packaging. Your care team is a message away.
Take the 2-minute quiz. Get matched to a protocol and the right labs.
Take the quiz →